Oliver Luxxe Assets LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1666239 GLADSTONE, NJ

Position in CPRX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,563,453

-$829,254 QoQ

Shares Held

49,744

-48.5% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

of 33 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names. CPRX ranks #3 (15.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc.	33,014	$2,584,005
3	CPRX	Catalyst Pharmaceuticals, Inc. This page	49,744	$1,563,453
4	INVA	Innoviva, Inc.	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc.	20,250	$41,107

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,563,453	49,744	-48.5%	Shares	Sole	2026-07-09
2026-03-31	$2,392,707	96,636	+25.4%	Shares	Sole	2026-04-08
2025-12-31	$1,798,276	77,047	+2.2%	Shares	Sole	2026-01-08
2025-09-30	$1,485,399	75,401	+5.8%	Shares	Sole	2025-10-24
2025-06-30	$1,545,908	71,240	+1.3%	Shares	Sole	2025-07-14
2025-03-31	$1,704,896	70,305	+106.6%	Shares	Sole	2025-05-14
2024-12-31	$710,101	34,025	0.0%	Shares	Sole	2025-01-21
2024-09-30	$676,417	34,025	—	Shares	Sole	2024-10-11
No filing history on record for this holder in this stock.